Suppr超能文献

Mir-765通过下调人肝细胞癌中INPP4B的表达促进细胞增殖。

Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.

作者信息

Xie Bin-Hui, He Xiao, Hua Rui-Xi, Zhang Bing, Tan Guo-Sheng, Xiong Shi-Qiu, Liu Liang-Shuai, Chen Wei, Yang Jian-Yong, Wang Xiao-Nong, Li He-Ping

机构信息

Department of General Surgery, the First Affiliated Hospital of Gannan Medical University, Guangzhou, Guangdong, China.

Department of Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.

出版信息

Cancer Biomark. 2016;16(3):405-13. doi: 10.3233/CBM-160579.

Abstract

microRNAs (miRNAs) dysregulation is widely involved in cancer progression and contributed to sustained cell proliferation by directly targeting multiple targets. Therefore, better understanding the underlying mechanism of miRNA in carcinogenesis may improve diagnostic and therapeutic strategies for malignancy. In our study, we found that mir-765 is upregulated in both hepatocellular carcinoma (HCC) cell lines and tissues, compared to human normal liver cell line and adjacent non-cancerous tissues, respectively. Overexpression of mir-765 increased HCC cells proliferation and tumorigenicity, whereas inhibition of mir-765 reverses this effect. Furthermore, we demonstrated that INPP4B as a direct target of mir-765 and ectopic expression of mir-765 repressed INPP4B expression, resulting in upregulation of p-AKT, Cyclin D1, and downregulation of p-FOXO3a, p21 expression in HCC. Strikingly, we found that silencing the expression of INPP4B is the essential biological function of miR-765 during HCC cell proliferation. Collectively, our findings reveal that miR-765 is a potential onco-miR that participates in carcinogenesis of human HCC by suppressing INPP4B expression, and might represent a potential therapeutic target for HCC patients.

摘要

微小RNA(miRNA)失调广泛参与癌症进展,并通过直接靶向多个靶点促进细胞持续增殖。因此,更好地理解miRNA在致癌过程中的潜在机制可能会改善恶性肿瘤的诊断和治疗策略。在我们的研究中,我们发现与人类正常肝细胞系和相邻非癌组织相比,mir-765在肝癌(HCC)细胞系和组织中均上调。mir-765的过表达增加了HCC细胞的增殖和致瘤性,而抑制mir-765则可逆转这种效应。此外,我们证明INPP4B是mir-765的直接靶点,mir-765的异位表达抑制了INPP4B的表达,导致HCC中p-AKT、细胞周期蛋白D1上调,p-FOXO3a、p21表达下调。引人注目的是,我们发现沉默INPP4B的表达是miR-765在HCC细胞增殖过程中的重要生物学功能。总的来说,我们的研究结果表明,miR-765是一种潜在的致癌miRNA,通过抑制INPP4B的表达参与人类HCC的致癌过程,可能是HCC患者的潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验